D&A Pharma: New confirmation for sodium oxybate in the treatment of alcohol dependence: a university thesis provides new evidence and explains its efficacy in maintaining abstinence

MONTBONNOT, France, June 7, 2023 /PRNewswire/ — While several effective treatments (benzodiazepines) are currently available for the treatment of alcohol withdrawal syndrome, there is an unmet medical need in the abstinence maintenance phase. With its broad mechanism of action on the…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.